Declining disease burden of HCC in the United States, 1992-2017: A population-based analysis.

Jianglong Han Bin Wang Wenmin Liu Shijie Wang Ruyan Chen Mingkai Chen Zhenming Fu

Published in: Hepatology (Baltimore, Md.) (2022)

We found significantly decreased overall HCC-specific mortality since 2013 in the US population, along with decreased incidence and continuously improved survival. The changing etiologies, advances in screening and diagnosis, and improved treatment modality and allocation might all contribute to the downward trends of the disease burden of HCC in the United States.

Keyphrases

risk factors
cardiovascular events
type diabetes
cardiovascular disease
coronary artery disease
replacement therapy
data analysis